159 related articles for article (PubMed ID: 30548777)
1. Prevention of mercaptopurine-induced hypoglycemia using allopurinol to reduce methylated thiopurine metabolites.
Miller MB; Brackett J; Schafer ES; Rau RE
Pediatr Blood Cancer; 2019 Apr; 66(4):e27577. PubMed ID: 30548777
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
Zhang M; Bostrom B
F1000Res; 2019; 8():176. PubMed ID: 30828444
[TBL] [Abstract][Full Text] [Related]
3. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine.
Gerich ME; Quiros JA; Marcin JP; Tennyson L; Henthorn M; Prindiville TP
J Crohns Colitis; 2010 Nov; 4(5):546-52. PubMed ID: 21122558
[TBL] [Abstract][Full Text] [Related]
5. Acral Skin Rash Caused by Altered Mercaptopurine Metabolism in Maintenance Therapy for B-Cell Acute Lymphoblastic Leukemia.
Newcome J; Geib KB; Thompson P; Gold S; Alexander TB
J Pediatr Hematol Oncol; 2022 Oct; 44(7):398-401. PubMed ID: 35180762
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
7. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Cao D; Hanauer SB
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529
[TBL] [Abstract][Full Text] [Related]
8. Thiopurines with low-dose allopurinol (ThiLDA)-a prospective clinical one-way crossover trial.
Chavoushi SF; Jharap B; Friedrich P; Smid K; Peters GJ; Malingré M
Eur J Clin Pharmacol; 2019 Dec; 75(12):1669-1674. PubMed ID: 31587102
[TBL] [Abstract][Full Text] [Related]
9. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
Barone T; Dandekar S; McKeone D; Mulieri K
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1987. PubMed ID: 38351548
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients With Suboptimal Metabolites Successfully Corrected With Allopurinol.
Vasta LM; Zanetti RC; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1003-e1009. PubMed ID: 32925411
[TBL] [Abstract][Full Text] [Related]
11. Use of allopurinol with low-dose 6-mercaptopurine in inflammatory bowel disease to achieve optimal active metabolite levels: a review of four cases and the literature.
Witte TN; Ginsberg AL
Can J Gastroenterol; 2008 Feb; 22(2):181-5. PubMed ID: 18299738
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Thiopurine Metabolites and Allopurinol in Pediatric Acute Lymphoblastic Leukemia: Consideration for an Algorithmic Approach.
Mosher N; Torkildson J; Golden C; Raphael R; Beach B; Michlitsch J; Feusner JH; Agrawal AK
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e521-e525. PubMed ID: 34486570
[TBL] [Abstract][Full Text] [Related]
13. Determination of 6-thioguanine and 6-methylmercaptopurine metabolites in renal transplantation recipients and patients with glomerulonephritis treated with azathioprine.
Chrzanowska M; Krzymański M
Ther Drug Monit; 1999 Apr; 21(2):231-7. PubMed ID: 10217345
[TBL] [Abstract][Full Text] [Related]
14. Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
Hoentjen F; Hanauer SB; de Boer NK; Rubin DT
Dig Dis Sci; 2012 Jan; 57(1):250-3. PubMed ID: 22147254
[TBL] [Abstract][Full Text] [Related]
15. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
Brackett J; Schafer ES; Leung DH; Bernhardt MB
Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133
[TBL] [Abstract][Full Text] [Related]
16. pH-Dependent 5-Aminosalicylates Releasing Preparations Do Not Affect Thiopurine Metabolism.
Takahashi K; Bamba S; Morita Y; Nishida A; Kawahara M; Inatomi O; Sugimoto M; Sasaki M; Andoh A
Digestion; 2019; 100(4):238-246. PubMed ID: 30602158
[TBL] [Abstract][Full Text] [Related]
17. Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia.
Conneely SE; Cooper SL; Rau RE
Front Oncol; 2020; 10():1129. PubMed ID: 32766146
[TBL] [Abstract][Full Text] [Related]
18. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
[TBL] [Abstract][Full Text] [Related]
19. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
Wall GC; Muktar H; Effken C; Mahajan PB
Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotide.
Hanai H; Iida T; Takeuchi K; Arai O; Watanabe F; Abe J; Maruyama Y; Oohata A; Ikeya K; Kageoka M; Miwa I; Yoshirou S; Hosoda Y; Kubota T
Inflamm Bowel Dis; 2010 Aug; 16(8):1376-81. PubMed ID: 20049951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
